The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Arlevert 20 mg/40 mg tablets

Hennig Arzneimittel GmbH & Co KGPA1238/001/001

Main Information

Trade NameArlevert 20 mg/40 mg tablets
Active SubstancesCinnarizine
Dosage FormTablet
Licence HolderHennig Arzneimittel GmbH & Co KG
Licence NumberPA1238/001/001

Group Information

ATC CodeN07CA Antivertigo preparations
N07CA52 cinnarizine, combinations


License statusAuthorised
Licence Issued13/07/2007
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back